Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2021

Chronic nerve injuries and delays in surgical treatment negatively
impact patient-reported quality of life
John M. Felder
Washington University School of Medicine in St. Louis

Ivica Ducic
Washington Nerve Institute, McLean, VA

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Felder, John M. and Ducic, Ivica, ,"Chronic nerve injuries and delays in surgical treatment negatively impact
patient-reported quality of life." Plastic and Reconstructive Surgery - Global Open. 9,5. . (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10490

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Original Article

Hand/Peripheral Nerve
Chronic Nerve Injuries and Delays in Surgical
Treatment Negatively Impact Patient-reported
Quality of Life
John M. Felder, MD*
Ivica Ducic, MD, PhD†
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Background: Little emphasis has been paid to characterize quality of life (QoL)
burdens experienced by patients seeking surgical treatment for nerve injuries and
neuropathic pain.
Methods: A cross-sectional survey was distributed to all patients (N = 767) from a
single nerve surgeon’s practice between 2014 and 2019. Data collected included
demographics, specifics of the injury and symptoms, time to referral, and effects of
the injury, surgery, and timing of surgery on QoL.
Results: Of the 767 patients, 209 (27.2%) completed the survey. Average age was 48.8
years; 68.9% of patients were women and 31.1% men. At presentation, 68% had experienced symptoms for more than 1 year; 86.1% reported severity as being profound;
97.6% reported QoL was at least moderately negatively impacted by nerve injury; 70%
felt they should have been referred earlier for surgical evaluation; 51.2% were not
told that nerve surgery was an option for their problem; 83.1% felt that earlier referral would have improved their QoL. After surgery, symptoms were significantly mitigated in 55.5% of the patients, moderately mitigated in 21.5%. Patients reported QoL
was significantly (59.8%) or at least moderately (76.6%) improved by nerve surgery.
Conclusions: The majority of patients reported that nerve injuries imparted a moderate to severe impact on QoL, and that surgical treatment improved QoL. Most
patients felt that earlier referral for surgical intervention would have led to better outcome and positively impacted QoL. Interdisciplinary treatment algorithms,
including a role for surgical intervention, may be helpful in facilitating timely
diagnosis, referral, and thus improved outcomes. (Plast Reconstr Surg Glob Open
2021;9:e3570; doi: 10.1097/GOX.0000000000003570; Published online 21 May 2021.)

INTRODUCTION

As peripheral nerves generate the signals that govern both
pain and peripheral motor function, dysfunction of peripheral nerves is inherently debilitating. Chronic nerve injuries
may be considered those injuries that manifest in patients
seeking outpatient care. These may result from an untreated
acute injury to a nerve, or may result from a progressive
chronic process, such as untreated compression neuropathy.
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Nerve injuries often present with an obvious loss of
function that may impart substantial disability and impair
activities of daily living, ability to work, or to pursue recreation.1–4 Untreated chronic neuropathic pain due to
nerve injury, although impossible to define objectively by
an examiner, may have a multitude of equally disabling
effects on an individual’s quality of life (QoL). Chronic
pain may induce or exacerbate psychological stress and
depression,5 and may result in chronic emotional, behavioral, and even personality changes.1 Furthermore,
chronic pain may interfere with ability to work, sleep,
engage in social activities, and ability to pursue leisure or
hobbies.1 Pain has been demonstrated to be specifically
predictive of negative changes in QoL and mood,6 and the
reported intensity of a patient’s pain has been shown to be
predictive of the level of disability imparted by the nerve
injury.2,3
Time since injury is also predictive of the level of
disability,2 and this time may be increased by delays in
referral, treatment and attempted treatment with ineffective modalities, whether medical or interventional.
Disclosure: The authors have no financial interest in relation to the content of this article.
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Table 1. Patient Demographics

Age
Survey respondents
Gender
Men
Women
Comorbidities
No major comorbidities
Anxiety
Depression
Peripheral vascular disease
Thyroid disorders
Autoimmune diseases
Diabetes
Cancer
Presenting symptoms
Pain
Numbness
Tingling/burning
Muscle weakness
Difficulty using arm or leg
Headaches/migraines
QoL variables affected
Sleep
Ambulation/use of extremity
Personal/social life
Professional activities
Mood/spirits

Avg 48.8

SD 19.1

No. of
Patients
209

Percentage
of Patients
27.2

65
144

31.1
68.9

77
65
59
31
23
18
13
10

36.8
31.1
28.2
14.8
11
8.6
6.2
4.8

192
82
129
45
46
111

91.9
39.2
61.7
21.5
22
53.1

164
92
183
150
175

78.5
44
87.6
71.8
83.7

Medications (opioids, neuroleptics, and antidepressants)
used chronically for pain related to nerve injuries may
themselves lead to further undesirable effects.7
Although neuropathic pain has been repeatedly demonstrated to represent a negative burden on QoL in
patients treated pharmacologically,7,8 there is surprisingly
little information available in the literature examining
QoL burdens reported by patients seeking nerve surgery, or examining the effect of nerve surgery on QoL.
We therefore sought to characterize the burden of nerve
injuries on QoL in patients seeking surgery for these conditions. The objectives of this study were (i) to characterize patient-reported effects of chronic nerve injuries on
quality of life, across a broad range of conditions presenting for ambulatory treatment; (ii) to examine the effect
of nerve surgery on patient-reported QoL, and (iii) to

characterize patients’ feelings about timing of referral to a
surgeon and delays in treatment.

METHODS

An institutional review board (IRB)-approved retrospective cross-sectional survey was distributed to all patients
(N = 767) from a single nerve surgeon’s (ID) ambulatory
referral-based practice between 2014 and 2019. Minimum
follow up was 1 year. Data collected included demographics,
reason of injury, concurrent clinical conditions, specifics of
nerve injury/disorder type, symptom of the injury and the
severity, time to referral, severity of the symptoms, how the
QoL was affected, feelings regarding the process of finding
treatment, post-surgery impacts on symptoms and QoL, and
complications of surgery.

RESULTS
Characteristics of the Patient Group

Of the 767 patients, 209 (27.2%) completed the survey.
Average age was 48.8 (SD = 19.1) years; 68.9% were women
and 31.1% men. Notable comorbidities included anxiety
(31.1%), depression (28.2%), and thyroid disorders (11.0%)
(Table 1). The composition of the response group versus
non-responders to the survey is characterized in Table 2.
Presenting symptoms included: pain 192 (91.9%),
numbness 82 (39.2%), tingling/burning 129 (61.7%),
muscle weakness 45 (21.5%), difficulty using arm or leg
46 (22%), headaches /migraines 111 (53.1%), and others
< 10% (Table 1).
Specifically, the symptoms affecting quality of life
included: sleep pattern in 78.5% of the patients, social life
in 87.5%, extremity function in 44.0%, personal/social
life in 87.6%, professional activities in 71.8%, and mood/
spirits in 83.7% (Table 1).
The duration of symptom before presentation is distributed as: <3 months (3.8%), 3–6 months (8.1%), 6–12 months
(20.1%), 1–2 years (25.8%), 3–5 years (21.1%), 5–10 years
(10.0%), and >10 years (11.0%). An estimated 68% (95% confidence interval [CI] = [61.2%, 74.2%]) of the patients had
symptoms for more than 1 year before surgery (Figs. 1, 2).

Table 2. Characteristics of Response Group versus Non-responders

Age
Mean ± SD
Gender
Women
WC versus insurance
WC
Surgery type
Neurolysis
Neuroma excision + implantation to muscle
Excision and reconstruction
Nerve tumor
Anatomical area
Head & neck
Breast/chest
Upper extremity
Lower extremity
Trunk/groin
WC, worker's compensation.
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All
(N = 767)

Responded
(N = 209)

Did Not Respond
(N = 558)

Responded versus
Did Not Respond

43.71 ± 18.52

48.80 ± 19.07

503 (65.58%)

144 (68.90%)

359 (64.33%)

P = 0.267

110 (14.34%)

28 (13.40%)

82 (14.70%)

P = 0.729

455 (59.32%)
42 (5.48%)
256 (33.38%)
14 (1.83%)

108 (51.67%)
7 (3.33%)
90 (42.86%)
4 (1.90%)

347 (62.18%)
35 (6.27%)
166 (29.74%)
10 (1.79%)

P = 0.011
P = 0.153
P = 0.001
P = 1.000

484 (63.10%)
4 (0.52%)
71 (9.26%)
163 (21.25%)
45 (5.87%)

118 (56.46%)
2 (0.96%)
20 (9.57%)
62 (29.67%)
6 (2.87%)

366 (65.59%)
2 (0.36%)
51 (9.14%)
101 (18.10%)
38 (6.99%)

P = 0.023
P = 0.300
P = 0.889
P = 0.001
P = 0.037
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Fig. 1. Symptom frequency and duration.

Fig. 2. Anatomical areas affected.

Anatomical areas affected included: head and neck
in 119 patients (56.9%), lower extremity in 62 (29.7%),
upper extremity in 19 (9.1%), trunk/groin in 6 (2.9%),
breast in 2 (1%), and multiple areas in 1 (0.5%) (Table 1).
An estimated 16.3% had spontaneous onset, 53.1% had
suffered a physical trauma, and 30.6% were precipitated
by previous surgery.
Surgery types included neurolysis in 108 (51.67%)
patients, neuroma excision with implantation to muscle
in 7 (3.33%), neuroma excision and nerve reconstruction
in 90 (42.86%), and excision of nerve tumor in 4 (1.90%)
(Table 2).

Severity of Symptoms before and after Surgery

86.1% (95% CI = [80.7%, 90.5%]) of the patients
reported the severity of symptoms at presentation being
profound, with a mean ± SD preoperative Likert scale
pain score of 8.1 ± 2 (median 9) (Fig. 3). After the surgery, 9.1% (95% CI = [5.6%, 13.8%]) reported that the
severity of symptoms was profound, a 77% reduction from
pre-surgery symptoms (P < 0.001 by McNemar’s test). The
mean ± SD Likert scale (0–10) pain severity score was 3.2 ±
3.0 (median=2). The change (reduction mean ± SD = 4.9
± 3.6; median = 5) was statistically significant (P < 0.001 by
the Wilcoxon Rank Sum test) (Fig. 4).
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Fig. 3. Symptom severity at time of presentation.

Fig. 4. The effect of nerve surgery on reduction of nerve symptom severity.

Patients reported that symptoms were significantly mitigated in 55.5% of the patients, moderately mitigated in
21.5%, somewhat mitigated in 10.0%, and 12.9% felt that
surgery was not helpful (Fig. 5).
Quality of Life before and after Surgery

84.7% (95% CI = [79.1%, 89.3%]) reported their QoL
was significantly negatively impacted by their nerve injury,
and 97.6% (95% CI = [94.5%, 99.2%]) reported their QoL
was at least moderately negatively impacted by their nerve
injury, which suggests with 95% statistical confidence that

4

more than 79.1% of the patients’ QoL was significantly
negatively impacted by their nerve injury (Fig. 6). 59.8%
(95% CI = [52.8%, 66.5%]) reported their QoL was significantly improved by their nerve surgery treatment; and
76.6% (95% CI = [70.2%, 82.1%]) reported their QoL was
at least moderately improved by their nerve surgery treatment (Fig. 7).
The surgery positively affected: 68.3% of those whose
sleep pattern was affected by the symptom; 75.0% of
those whose extremity function was affected by the
symptom; 74.9% of those whose personal/social life was

Felder and Ducic • Quality of Life Burden in Nerve Injuries

Fig. 5. The degree to which nerve surgery helped resolve nerve symptoms.

Fig. 6. Impact of nerve injuries on quality of life at presentation.

affected by the symptom; 66.0% of those whose professional productivity was affected by the symptom; and
76.6% of those whose mood/spirits was affected by the
symptom (Fig. 7).
Treatment Experiences before Surgery and Feelings on the
Referral Process

With regard to treatment experiences before the presentation, the distribution of total number of physicians
seen: 0 (0%), 1–3 (28.7%), 4–6 (42.1%), 7–10 (16.7%),

11–15 (7.7%), 16–20 (4.8%) (Fig. 8). In total, 70.0% (95%
CI = [63.1%, 76.0%]) felt they should have been referred
earlier; 51.2% (95% CI = [44.2%, 58.2%]) were not told
that nerve surgery was an option for their problem; and
68.8% (95% CI = [62.0%, 75.0%]) were told that nothing
could be done. An estimated 83.1% (95% CI = [77.3%,
87.9%]) felt that earlier referral would have improved
their quality of life, and 88.5% (95% CI = [83.3%, 92.5%])
stated that if they could go back in time, they would have
the surgery again (Figs. 9–11).
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Fig. 7. Impact of nerve surgery on improving quality of life.

Fig. 8. Other physicians seen before referral to nerve surgeon.

The average overall satisfaction with nerve surgery
was 8.04/10—48.8% rated 10/10 (Fig. 12). Complication
rate was 8.3%, and all complications were minor (delayed
wound healing, dehiscence due to noncompliance, infection requiring oral antibiotics), with no complications
requiring hospitalization or return to the operating room
(Fig. 13).

DISCUSSION

Traditional outcomes reporting in nerve surgery
focuses on objective clinical motor or sensory grading
systems. However, patients themselves may experience
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the impact of nerve injuries and outcome of nerve surgeries very differently. The pain and bodily dysfunction that
clinicians seek to characterize are in reality only some of
the contributors to the overall negative impact that nerve
injuries create on a patient’s quality of life. Pain and sensory/motor dysfunction are a problem because they create a negative change in patients’ standard of living that
they are unable to overcome without medical intervention. This negative chapter in a patient’s life story can be
unduly extended when treating clinicians do not diagnose the problem correctly or do not refer the patient for
appropriate nerve surgery intervention, which is often the
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Fig. 9. Patients’ feelings and experiences regarding referral process.

Fig. 10. Patients’ feelings regarding availability of information for treatment options.

only means of permanently restoring or at least approximating the patient’s prior quality of life.
It has been our observation over 2 decades of clinical
practice that patients’ interpretation of their experience
does not always correlate with either objective outcome
measures, or validated surrogate measures aimed at quantifying QoL variables. Therefore, this study was designed
to directly query surgical patients’ perceptions of the
quality of life changes imparted by nerve injuries, and the
effect of nerve surgery on quality of life. This study was
administered as a cross-sectional survey intended to capture patient perceptions following the conclusion of their
experience with nerve surgery. Although outcomes such
as pain scores were included in the study results, this study
was not intended to be a validated outcomes study for pain
or physical function. Rather, traditional outcome measures were only included to allow patients to give context

to their subjective QoL responses, which were the primary
data collected. The goal, simply, was to understand to what
extent nerve injuries had a negative impact on quality of
life, and whether nerve surgery broadly was helpful in
improving QoL for these patients.
Findings of this study included characterization of the
symptoms associated with nerve injuries that patients felt
affected their QoL, the subjective severity of these symptoms, and their impact on QoL (Table 1, Figs. 1, 3, 6).
Respondents in our study reported chronic nerve injuries
affected the QoL domains of sleep, social functioning, and
global QoL; findings that are in concordance with other
studies that have used the SF-36 (short form 36) to demonstrate an impact of medically-treated neuropathic pain
on these domains.8 Our patients further reported impacts
on professional activities, mood, and ambulation or use
of extremity (as we queried patients with a broader set of
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Fig. 11. Patients’ feelings on timeliness of referral and outcome.

Fig. 12. Patient satisfaction with nerve surgery.

nerve injuries rather than only those causing neuropathic
pain) (Table 1).
A majority of our patients reported chronic symptoms that were substantially disabling in their frequency,
duration, and severity (Figs. 1, 3). Regarding the negative impact of nerve injury symptoms on QoL, 97.6% of
patients reported at least a moderate impact, and 84.7%
reported a significant impact on QoL (Fig. 6). The finding of a negative impact on QoL is in agreement with
prior population survey studies, wherein respondents
with medically-treated neuropathic pain had lower SF-36
HR-QOL (short form 36 health-related quality of life)
scores than patients with non-neuropathic pain, even after
adjusting for pain score.9,10 Taken together, our findings
regarding duration and severity of symptoms, and level of
impact on QoL indicate that this subset of nerve injury
patients presenting for ambulatory nerve surgery had relatively chronic, established conditions with a pronounced
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negative effect on QoL; perhaps because they are referred
for surgery after other conditions have been tried and
failed.
Although there are a multitude of published studies
that report the outcome of nerve surgery in terms of VAS
(visual analog scale) pain reduction and changes in a variety of physical functioning metrics, there are surprisingly
few reports of the direct effect of nerve surgery on QoL.11
Yang et al demonstrated an improvement in SF-36 scores
in patients undergoing lower extremity nerve decompression surgery for painful diabetic neuropathy, in a case
series of 19 patients.12 Domeshek et al reported a statistically significant improvement in QoL rated on a VAS
scale in a case series of 70 patients with upper and lower
extremity neuromas.13 However, a meta-analysis examining
surgical treatment of painful neuromas did not identify
meaningful reporting on QoL from other publications.11
Our results echo those of the few other studies reporting
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Fig. 13. Safety of nerve surgery.

improvement in QoL following surgical treatment for
nerve injuries, and our results are notable in comparison for examining both a larger cohort of patients and
a broader range of chronic nerve injury conditions. The
majority of respondents in our study reported that nerve
surgery improved QoL to a significant (59.8%) or at least
moderate (76.6%) degree, and at least 65% of patients
reported specific improvements in each of the domains
of sleep pattern, extremity function, personal/social life,
professional productivity, and mood (Fig. 7). These data
support the existing body of literature demonstrating that
nerve injuries are associated with a negative impact on
quality of life14–16 and that surgical treatment of nerve injuries is an important consideration in patients’ care when a
reasonable short period of conservative measures has not
led to resolution of symptoms.3,11,13,17
The study findings also provided a description of the
process of finding care for nerve injuries. Survey results
confirmed that most patients had seen multiple specialists
before referral for nerve surgery evaluation, and that many
patients experienced subjective frustrations and delays
during the referral process before ultimately undergoing
evaluation by a nerve surgeon (Figs. 9–11). The majority
of patients felt that they should have been referred earlier
(Fig. 9), and most patients either were not told that nerve
surgery was an option for them, or were told that nothing
could be done for their problem (Figs. 9, 10). Notably,
77% of patients felt that they were not managed in a timely
manner and 83.1% felt that earlier referral would have
improved their quality of life. We are not able to confirm
with this study whether earlier surgical treatment would
have improved outcomes of our patients in terms of pain
reduction; however, Kato et al have demonstrated that
delayed surgical treatment of brachial plexus injuries are
associated with poorer pain outcomes in addition to the

expected poorer functional outcomes.18 These findings
appear to validate the assumption of many nerve surgeons
that closer interdisciplinary care of nerve injury patients
would reduce suffering for the patient and hasten recovery in their personal, daily, professional, and social lives.
The overall importance of our findings should be interpreted in the context of interdisciplinary management
and of the existing literature regarding management of
chronic neuropathic pain. Outside of surgical literature
and practice, the term “neuropathic pain” is broad, and
includes pain resulting from phenomena varying from
nonsurgical conditions such as postherpetic neuralgia, to
conditions such as neuroma that result from nerve injury
and have been repeatedly demonstrated to respond to surgery.19 The predominance of published literature regarding management of chronic neuropathic pain is medical
or pharmacologic in scope and tends not to consider conditions leading to neuropathic pain as surgically-treatable
injuries of nerves. Thus, even though parallel surgical literature offers clear recommendations on timing for surgical intervention for all types of nerve injuries, none of
this literature is included in commonly referenced treatment algorithms,20 guidelines,21–24 and society consensus
statements25 that are used to guide medical treatment of
chronic nerve injuries.
There are multiple examples of conditions whose
pathophysiology and treatment are viewed differently by
medical and surgical providers, and for which a shared
terminology and concept of disease would likely improve
multidisciplinary management to the benefit of patients.
Our study population included, for instance, those with
neuromas undergoing excision or excision and reconstruction, those with painful diabetic neuropathy related
to nerve compression, those with complex regional pain
syndrome, and those with chronic headaches related to
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sensory nerve entrapment or injury. Multiple publications have shown that surgical treatment of neuromas
improves pain11,26,27 and quality of life.13 Surgical literature is also replete with studies demonstrating improvements in pain,28–31 sensibility,32–34 and quality of life12 after
nerve decompression in painful diabetic neuropathy—a
condition for which only pharmacologic treatment is traditionally considered in nonsurgical literature,20–25 despite
extensive publications examining its negative impact on
quality of life.35–38 Chronic migraine headaches, although
traditionally considered a source of neuropathic pain
only treatable with chronic medication, have also been
repeatedly demonstrated to be treatable with surgical
decompression of entrapped sensory nerves,38–41 or excision of neuroma in cases of nerve injury masquerading as
headaches such as in postoperative headaches following
acoustic neuroma excision that are associated with occipital nerve neuromas.42,43 The same circumstance has lately
been recognized in phantom limb pain—a condition traditionally treated pharmacologically that has now been
shown to be treatable with nerve transfer surgery.44,45 The
greatest barrier to effective multidisciplinary treatment
for these conditions seems to be one of terminology and
ideation, and it may be this barrier that is partially responsible for our findings of delayed presentation for surgical
treatment. It stands to reason, therefore, that unified algorithms with common terminology and incorporating both
medical and surgical recommendations for treatment
would improve patients’ outcomes and decrease the quality of life burden experienced by patients with chronic
nerve injuries.
Limitations of the study include a relatively low response
rate, which may have to do with attrition of respondents
over a long study period. There were differences in survey
response rates among surgery types; however, the percentage of respondents by surgery type generally approximated
the percentage of the patients who had undergone that
surgery type. The retrospective nature of the survey relies
on patient recall, possibly affecting outcome interpretation. However, ultimately, it is the patient’s final impression of the experience after completion of treatment that
we are concerned with. Arguably, the lack of a validated
outcomes measure for quality of life is a weakness; however, we were specifically interested in patients’ responses
to direct questions regarding QoL and the referral process,
rather than validated but less specific surrogate measures.
Despite these study limitations, this preliminary report
does serve to call awareness to the issues of decreased quality of life and delays in referral for surgical care in patients
suffering from chronic nerve injuries. Future prospective
studies utilizing validated patient-reported outcome tools
that measure QoL would add further perspective to these
preliminary but significant findings.

CONCLUSIONS

Among patients with nerve injury referred for nerve
surgery, most report decreased quality of life associated
with their injury. Nerve injury patients also report that
the referral process of finding appropriate surgical care
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may be frustrating or protracted, and that this further
negatively impacts their ultimate outcome and quality of
life. Greater recognition of the quality of life burden that
nerve injury patients face while finding appropriate surgical care for their condition should highlight the need
for closer interdisciplinary management of these patients.
Treatment algorithms incorporating both medical and
surgical perspectives on the treatment of chronic neuropathic pain would improve interdisciplinary management.
Ivica Ducic, MD, PhD
The George Washington University
Washington Nerve Institute
7601 Lewinsville Road, Suite 460
McLean, VA 22102
E-mail: dr.ducic@gmail.com
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